Athira Pharma, Inc. (ATHA)

Athira Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	48.44	90.58	95.97	110.54	60.63
Short-Term Investments	2.84	56.84	104.38	143.22	124.06
Cash & Short-Term Investments	51.28	147.42	200.34	253.76	184.68
Cash Growth	-65.22%	-26.42%	-21.05%	37.40%	8882.59%
Accounts Receivable	-	-	1.23	2.34	1.3
Other Receivables	-	1.63	-	-	-
Receivables	-	1.63	1.23	2.34	1.3
Prepaid Expenses	3.57	5.68	5.96	4.7	6.36
Total Current Assets	54.84	154.73	207.53	260.8	192.34
Property, Plant & Equipment	3.25	4.44	5.32	5.22	3.59
Long-Term Investments	-	-	44.83	65.94	83.51
Other Long-Term Assets	0.69	1.08	0.48	0.06	0.13
Total Assets	58.78	160.25	258.15	332.01	279.56
Accounts Payable	0.32	0.13	2.5	0.57	1.16
Accrued Expenses	12.4	28.34	18.6	8.44	3.12
Current Portion of Leases	0.41	0.37	0.33	0.29	0.12
Total Current Liabilities	13.14	28.84	21.43	9.29	4.41
Long-Term Leases	0.8	1.22	1.59	1.63	0.88
Total Liabilities	13.94	30.06	23.02	10.92	5.28
Common Stock	0	0	0	0	0
Additional Paid-In Capital	450.98	439.74	428.62	417.36	315.29
Retained Earnings	-406.15	-309.21	-191.53	-95.9	-41.04
Comprehensive Income & Other	0	-0.35	-1.96	-0.39	0.03
Total Common Equity	44.84	130.19	235.14	321.08	274.28
Shareholders' Equity	44.84	130.19	235.14	321.08	274.28
Total Liabilities & Equity	58.78	160.25	258.15	332.01	279.56
Total Debt	1.22	1.59	1.91	1.92	1
Net Cash (Debt)	50.06	145.83	198.43	251.84	183.68
Net Cash Growth	-65.67%	-26.51%	-21.21%	37.11%	36417.30%
Net Cash Per Share	1.30	3.84	5.26	6.82	15.35
Filing Date Shares Outstanding	39.04	38.33	37.94	37.62	37.12
Total Common Shares Outstanding	39.04	38.17	37.88	37.38	32.49
Working Capital	41.71	125.89	186.1	251.51	187.93
Book Value Per Share	1.15	3.41	6.21	8.59	8.44
Tangible Book Value	44.84	130.19	235.14	321.08	274.28
Tangible Book Value Per Share	1.15	3.41	6.21	8.59	8.44
Machinery	1.42	1.4	1.13	0.59	0.08
Construction In Progress	-	-	-	1.12	2.64
Leasehold Improvements	4.32	4.32	4.3	2.56	-

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q